Cite
HTAD patient pathway: Strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD). A statement from the HTAD working group of VASCERN.
MLA
Caruana, Maryanne, et al. “HTAD Patient Pathway: Strategy for Diagnostic Work-up of Patients and Families with (Suspected) Heritable Thoracic Aortic Diseases (HTAD). A Statement from the HTAD Working Group of VASCERN.” European Journal of Medical Genetics, vol. 66, no. 1, Jan. 2023, p. 104673. EBSCOhost, https://doi.org/10.1016/j.ejmg.2022.104673.
APA
Caruana, M., Baars, M. J., Bashiardes, E., Benke, K., Björck, E., Codreanu, A., de Moya Rubio, E., Dumfarth, J., Evangelista, A., Groenink, M., Kallenbach, K., Kempers, M., Keravnou, A., Loeys, B., Muiño-Mosquera, L., Nagy, E., Milleron, O., Nistri, S., Pepe, G., … Jondeau, G. (2023). HTAD patient pathway: Strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD). A statement from the HTAD working group of VASCERN. European Journal of Medical Genetics, 66(1), 104673. https://doi.org/10.1016/j.ejmg.2022.104673
Chicago
Caruana, Maryanne, Marieke J Baars, Evy Bashiardes, Kalman Benke, Erik Björck, Andrei Codreanu, Elena de Moya Rubio, et al. 2023. “HTAD Patient Pathway: Strategy for Diagnostic Work-up of Patients and Families with (Suspected) Heritable Thoracic Aortic Diseases (HTAD). A Statement from the HTAD Working Group of VASCERN.” European Journal of Medical Genetics 66 (1): 104673. doi:10.1016/j.ejmg.2022.104673.